Manufacturers Life Insurance Company, The Immunovant, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Immunovant, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 35,908 shares of IMVT stock, worth $987,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,908
Previous 36,680 2.1%
Holding current value
$987,829
Previous $1.01 Million 2.18%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
N/A
-772 Reduced 2.1%
35,908 $987,000
Q3 2024

Nov 13, 2024
SELL
$27.51 - $27.51 $26,024 - $26,024
-946 Reduced 2.51%
36,680 $1.01 Million
Q2 2024

Aug 14, 2024
SELL
$25.1 - $31.61 $1 Million - $1.26 Million
-39,877 Reduced 51.45%
37,626 $993,000
Q1 2024

May 14, 2024
BUY
$30.27 - $43.79 $458,772 - $663,681
15,156 Added 24.31%
77,503 $2.5 Million
Q4 2023

Feb 13, 2024
BUY
$31.31 - $44.19 $22,856 - $32,258
730 Added 1.18%
62,347 $2.63 Million
Q3 2023

Nov 15, 2023
BUY
$18.55 - $39.96 $709,314 - $1.53 Million
38,238 Added 163.56%
61,617 $2.37 Million
Q2 2023

Aug 11, 2023
SELL
$14.2 - $23.75 $100,181 - $167,556
-7,055 Reduced 23.18%
23,379 $443,000
Q1 2023

May 15, 2023
BUY
$15.27 - $19.72 $308,316 - $398,166
20,191 Added 66.34%
50,625 $785,000
Q4 2022

Aug 11, 2023
BUY
$6.59 - $17.75 $66,941 - $180,304
10,158 Added 50.1%
30,434 $540,000
Q4 2022

Feb 13, 2023
BUY
$6.59 - $17.75 $200,560 - $540,203
30,434 New
30,434 $540,000
Q2 2022

Aug 15, 2022
SELL
$3.38 - $5.65 $68,532 - $114,559
-20,276 Closed
0 $0
Q1 2022

Aug 11, 2023
SELL
$5.06 - $8.77 $153,565 - $266,160
-30,349 Reduced 59.95%
20,276 $111,000
Q1 2022

May 20, 2022
SELL
$5.06 - $8.77 $21,429 - $37,140
-4,235 Reduced 17.28%
20,276 $112,000
Q4 2021

Feb 16, 2022
BUY
$7.33 - $9.32 $637 - $810
87 Added 0.36%
24,511 $209,000
Q3 2021

Nov 12, 2021
BUY
$7.01 - $11.37 $14,097 - $22,865
2,011 Added 8.97%
24,424 $212,000
Q2 2021

Aug 12, 2021
SELL
$9.4 - $16.85 $2,500 - $4,482
-266 Reduced 1.17%
22,413 $237,000
Q1 2021

May 03, 2021
BUY
$13.08 - $49.6 $667 - $2,529
51 Added 0.23%
22,679 $364,000
Q4 2020

Feb 12, 2021
BUY
$36.36 - $52.71 $127,659 - $185,064
3,511 Added 18.37%
22,628 $1.05 Million
Q3 2020

Nov 09, 2020
BUY
$22.61 - $38.9 $180,880 - $311,200
8,000 Added 71.96%
19,117 $673,000
Q2 2020

Aug 10, 2020
BUY
$13.87 - $28.44 $154,192 - $316,167
11,117 New
11,117 $283,000

Others Institutions Holding IMVT

# of Institutions
218
Shares Held
67.1M
Call Options Held
2.48M
Put Options Held
561K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email